Varian Medical Systems (VAR) Releases FY18 Earnings Guidance
Varian Medical Systems (NYSE:VAR) updated its FY18 earnings guidance on Friday. The company provided earnings per share guidance of ~$4.05-4.17 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.30. The company issued revenue guidance of +3-5% to ~$2.78-2.8 billion, compared to the consensus revenue estimate of $2.76 billion.
Varian Medical Systems (VAR) opened at $111.53 on Friday. Varian Medical Systems has a 52 week low of $76.94 and a 52 week high of $114.09. The stock has a market cap of $10,220.00, a P/E ratio of 40.41, a price-to-earnings-growth ratio of 3.26 and a beta of 0.68.
Varian Medical Systems (NYSE:VAR) last issued its quarterly earnings results on Wednesday, October 25th. The medical equipment provider reported $1.09 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.19 by ($0.10). Varian Medical Systems had a net margin of 8.85% and a return on equity of 23.68%. The company had revenue of $739.00 million for the quarter, compared to analyst estimates of $741.69 million. During the same quarter in the previous year, the company posted $1.03 EPS. The company’s revenue for the quarter was down 1.1% compared to the same quarter last year. research analysts forecast that Varian Medical Systems will post 4.25 earnings per share for the current year.
In other Varian Medical Systems news, SVP John W. Kuo sold 7,991 shares of the business’s stock in a transaction on Monday, January 8th. The shares were sold at an average price of $110.65, for a total value of $884,204.15. Following the transaction, the senior vice president now directly owns 27,363 shares of the company’s stock, valued at approximately $3,027,715.95. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Kolleen T. Kennedy sold 931 shares of the business’s stock in a transaction on Wednesday, October 18th. The shares were sold at an average price of $105.00, for a total transaction of $97,755.00. Following the completion of the transaction, the executive vice president now directly owns 27,531 shares in the company, valued at $2,890,755. The disclosure for this sale can be found here. Insiders sold 111,727 shares of company stock valued at $12,392,515 in the last quarter. 0.78% of the stock is owned by insiders.
About Varian Medical Systems
Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.